ROCKET PHARMACEUTICALS ANNOUNCES POSITIVE CLINICAL SAFETY UPDATE FROM INITIAL THREE PATIENTS TREATED WITH RP-A501 UNDER MODIFIED PHASE 2 PROTOCOL FOR DANON DISEASE

Reuters · 3d ago

Please log in to view news